Ci Investments Inc. Royalty Pharma PLC Transaction History

Ci Investments Inc.

$26.5 Billion
Q4 2024

A detailed history of Ci Investments Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Ci Investments Inc. holds 11,631 shares of RPRX stock, worth $392,778. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,631

Previous 10,015 16.14%

Holding current value

$392,778

Previous $283,000 4.95%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$24.28 - $28.39 $39,236 - $45,878	1,616 Added 16.14%	11,631 $297,000
Q3 2024 Nov 12, 2024	SELL	$25.63 - $29.27 $922 - $1,053	-36 Reduced 0.36%	10,015 $283,000
Q2 2024 Aug 12, 2024	SELL	$26.26 - $29.9 $38,917 - $44,311	-1,482 Reduced 12.85%	10,051 $265,000
Q1 2024 May 13, 2024	BUY	$27.46 - $31.33 $144,549 - $164,921	5,264 Added 83.97%	11,533 $350,000
Q4 2023 Feb 12, 2024	SELL	$26.21 - $29.22 $27,284 - $30,418	-1,041 Reduced 14.24%	6,269 $176,000
Q3 2023 Nov 13, 2023	SELL	$26.26 - $31.38 $25,130 - $30,030	-957 Reduced 11.58%	7,310 $198,000
Q2 2023 Aug 11, 2023	BUY	$29.6 - $36.56 $118,607 - $146,495	4,007 Added 94.06%	8,267 $254,000
Q1 2023 May 12, 2023	BUY	$32.77 - $39.4 $88,151 - $105,986	2,690 Added 171.34%	4,260 $153,000
Q4 2022 Feb 10, 2023	BUY	$39.17 - $44.04 $23,697 - $26,644	605 Added 62.69%	1,570 $62,000
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $17,028 - $19,065	427 Added 79.37%	965 $39,000
Q2 2022 Aug 12, 2022	SELL	$37.53 - $44.22 $43,084 - $50,764	-1,148 Reduced 68.09%	538 $23,000
Q1 2022 May 12, 2022	SELL	$37.46 - $42.44 $8,316 - $9,421	-222 Reduced 11.64%	1,686 $66,000
Q4 2021 Feb 11, 2022	BUY	$35.17 - $42.48 $18,007 - $21,749	512 Added 36.68%	1,908 $76,000
Q3 2021 Nov 12, 2021	BUY	$36.14 - $42.24 $50,451 - $58,967	1,396 New	1,396 $50,000

Others Institutions Holding RPRX

# of Institutions

431

Shares Held

294M

Call Options Held

508K

Put Options Held

118K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.8B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.

Account

Ci Investments Inc. Royalty Pharma PLC Transaction History